Indices dipped after Johnson & Johnson (JNJ.US) release results of coronavirus vaccine trials. The company said that its one-shot vaccine is 66% effective overall in moderate to severe cases, according to findings of the global clinical trial. Shots were generally well tolerated among trial participants. This is a slightly disappointing result given that some available vaccines have prevented virus infections in over 90% of cases. However, the vaccine is said to be 85% effective in preventing severe cases. Company plans to file for the emergency use approval in the United States in early February.
DE30 dropped around 1% following lacklustre results of Johnson&Johnson coronavirus vaccine trials. Source: xStation5
๐ฅDaily Summary: Tech Sector Crash on Wall Street and Historic Attack on Binance
๐ดThree Markets to Watch Next Week: US500, BITCOIN, EURUSD (30.10.2026)
US OPEN: Bloody end to the quarter. Intel loses nearly 1/3 of its value, and the crypto market shakes off a hack on the largest exchange.
Market Wrap: Binance Hack Shakes Markets. European Equities Under Pressure